Activation of the T cell antigen receptor (TCR) by antigen and costimulation via the coreceptor CD28 induces proliferation and interleukin 2 (IL-2) production of CD4 + helper T lymphocytes 1 . Once they are instructed to proliferate, the clonal expansion of helper T lymphocytes becomes independent of further antigenic stimulation 1, 2 and is promoted by paracrine or autocrine . To initiate and perpetuate the proliferation of helper T cells, T cell-activation signals such as signaling by TCR-CD28 and the IL-2 receptor (IL-2R) must inhibit the transcription factor Foxo1, which blocks cell cycle progression in resting cells via induction of the cell cycle inhibitor p27 Kip1 (ref. 4). Foxo1 also induces the proapoptotic protein Bim 4 , which is blocked by the antiapoptotic protein Bcl-2 in resting helper T lymphocytes but not in activated helper T lymphocytes 5 . In the initial phase of activation, Foxo1 protein is rapidly inactivated by the post-translational modification of phosphorylation dependent on TCR-CD28 signaling. This post-translational modification leads to exclusion of Foxo1 from the nucleus and promotes its functional inactivation 4, 6 . However, signaling through the TCR and IL-2R is short-lived, and how Foxo1 is repressed in the late phase of clonal expansion has remained unclear.
A r t i c l e s
Activation of the T cell antigen receptor (TCR) by antigen and costimulation via the coreceptor CD28 induces proliferation and interleukin 2 (IL-2) production of CD4 + helper T lymphocytes 1 . Once they are instructed to proliferate, the clonal expansion of helper T lymphocytes becomes independent of further antigenic stimulation 1, 2 and is promoted by paracrine or autocrine IL-2 (ref. 3) . To initiate and perpetuate the proliferation of helper T cells, T cell-activation signals such as signaling by TCR-CD28 and the IL-2 receptor (IL-2R) must inhibit the transcription factor Foxo1, which blocks cell cycle progression in resting cells via induction of the cell cycle inhibitor p27 Kip1 (ref. 4) . Foxo1 also induces the proapoptotic protein Bim 4 , which is blocked by the antiapoptotic protein Bcl-2 in resting helper T lymphocytes but not in activated helper T lymphocytes 5 . In the initial phase of activation, Foxo1 protein is rapidly inactivated by the post-translational modification of phosphorylation dependent on TCR-CD28 signaling. This post-translational modification leads to exclusion of Foxo1 from the nucleus and promotes its functional inactivation 4, 6 . However, signaling through the TCR and IL-2R is short-lived, and how Foxo1 is repressed in the late phase of clonal expansion has remained unclear.
Here we show that in the late phase of clonal expansion, expression of Foxo1 was regulated post-transcriptionally by the microRNA (miRNA) miR-182, which is a member of the miR-183-miR-96-miR-182 cluster 7 and is induced by IL-2R signaling. Activated STAT5 (signal transducer and activator of transcription 5) bound directly to the regulatory region of miR-182 and induced its expression. Moreover, miR-182 bound to a specific site of the 3′ untranslated region (UTR) of Foxo1 mRNA and decreased its expression. In activated helper T lymphocytes, we found that specific inhibition of miR-182 resulted in more Foxo1 and less clonal expansion. Constitutive overexpression of miR-182 in activated helper T lymphocytes resulted in much more clonal expansion. In a transfer model of ovalbumin (OVA)-induced arthritis, inhibition of miR-182 in helper T lymphocytes resulted in lower disease severity. Thus, our results indicate a critical contribution of miR-182 to the regulation of helper T cell population expansion.
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RESULTS

Induction of miR-182 in activated helper T cells
We activated mouse naive (CD4 + CD62L hi CD25 − ) helper T cells in vitro under polarizing conditions for the generation of T helper type 1 (T H 1), T H 2 and IL-17-producing (T H 17) cells in culture. We assessed expression of miR-96, miR-182 and miR-183 by quantitative PCR. We were not able to detect miR-96 in either naive or activated cells (data not shown). We found that miR-182 and miR-183 were both expressed in naive and in activated cells (Fig. 1a) . In naive cells, miR-182 expression was threefold higher than miR-183 expression. At 6 d after activation, expression of miR-182 and miR-183 was much higher in helper T lymphocytes in all culture conditions than in naive helper T cells (Fig. 1a) ; miR-182 expression was 50-to 200-fold higher and miR-183 expression was 20-to 50-fold higher.
Regardless of the polarizing culture conditions, expression of miR-182 increased between days 1 and 2 and reached a peak expression around day 3 (Fig. 1b) and decreased thereafter ( Supplementary  Fig. 1a) . Nonactivated naive CD4 + T cells did not upregulate miR-182 expression (Fig. 1b) . There was no substantial difference among T H 0, T H 1, T H 2 and T H 17 cells in miR-182 expression. We observed similar kinetics for miR-182 expression in human naive (CD45RA + ) and memory (CD45RO + ) helper T cells (Supplementary Fig. 1b,c) .
The considerable induction of miR-182 and miR-183 suggests a critical role for these miRNAs in activated helper T cells.
Foxo1 is a target of miR-182 in activated helper T cells
Computational target prediction with the PicTar algorithm 8 and TargetScan5.1 algorithm 9 showed Foxo1 was a putative target for the miRNAs of the miR-183-miR-96-miR-182 cluster. To confirm Foxo1 mRNA as a target of miR-96, miR-182 and/or miR-183, we cloned regions of the 3′ UTR (>3,000 nucleotides) of Foxo1 mRNA containing the predicted conserved overlapping binding sites for miR-96 and miR-182 and the binding site for miR-183 (nucleotides 1-174), only the miR-183-binding site (nucleotides 55-132), or only the overlapping miR-96-and miR-182-binding sites (nucleotides 105-191) into a retroviral vector downstream of a reporter gene encoding truncated human CD4 (Supplementary Fig. 2 ). We activated mouse naive CD4 + helper T cells for 36 h and transduced these cells with the retroviral vectors. Reporter gene expression was suppressed by 20-40% over a culture period of 4 weeks in cells carrying the vectors containing the predicted overlapping binding sites for miR-96 and miR-182 but not in cells carrying the vector containing only the predicted miR-183-binding site (Fig. 2a) .
We confirmed the functional relevance of the predicted overlapping binding sites for miR-96 and miR-182 by mutating the sequence from GUGCCAAA to GACGGUAA. The observed suppression of reporter gene expression was reverted in this mutant (Fig. 2b) . These experiments identified Foxo1 as a target of miR-182 in activated helper T lymphocytes. In these cells, Foxo1 was targeted only by miR-182 but not by miR-96, which was not expressed.
Dynamics of the regulation of Foxo1 expression
We quantified Foxo1 mRNA and miR-182 in activated mouse and human helper T cells. As expected, miR-182 and Foxo1 mRNA showed a negative correlation in mouse helper T cells (Fig. 3a) and human helper T cells (Supplementary Fig. 3) , with increasing miR-182 and decreasing Foxo1 mRNA over time. To further confirm the interaction of miR-182 and Foxo1, we inhibited miR-182 by using locked nucleic acid (LNA) oligomers 10 or antagomir oligonucleotides; each bound and inhibited the mature miRNA. Treatment of activated helper T cells with LNA-182 blocked miR-182 expression by 60%, whereas Foxo1 mRNA expression was 20% higher and Foxo1 protein expression was 50% higher (Supplementary Fig. 4a-c) . With antagomirs, miR-182 was blocked by more than 90% (Fig. 3b) , whereas Foxo1 mRNA expression was 60% higher and Foxo1 protein expression was 50% higher (Fig. 3c,d) .
Phosphorylated Foxo1 is exported from the nucleus and is therefore inactive 4 A r t i c l e s (data not shown) but was rapidly induced by activation as early as 1 h later. The ratio of total Foxo1 to phosphorylated Foxo1 remained low for 66 h (Fig. 3e) . Thereafter, the ratio of total Foxo1 to phosphorylated Foxo1 increased about fourfold for the rest of the observation period until 112 h after onset of activation (Fig. 3e) . The amount of total Foxo1 protein decreased gradually and remained low until 112 h after activation (Fig. 3f) . These results indicate that suppression of Foxo1 in activated helper T lymphocytes is mediated initially by post-translational modification until about 66 h after the onset of activation and is mediated thereafter by transcriptional and/or posttranscriptional regulation.
IL-2 is required for the induction of miR-182
We activated naive helper T cells in vitro in the presence or absence of recombinant IL-2. IL-2 induced miR-182 expression in a dose-dependent way (Fig. 4a) . Conversely, miR-182 expression was inhibited by 80% through the use of blocking antibodies to IL-2 and CD25 (IL-2R α-chain; Fig. 4b ), which suggested that IL-2R signaling promotes miR-182 expression.
IL-2R signaling activates STAT5 (ref. 11). Notably, the intergenic miR-183-miR-96-miR-182 cluster contains several phylogenetically conserved binding sites for STAT5. After activation of naive helper T cells, we were able to assess the binding of STAT5 to a predicted STAT5-binding site by chromatin immunoprecipitation (Fig. 4c and Supplementary Fig. 5a-c) . Specific inhibition of STAT5 activity with the chromone-based inhibitor nicotinyl hydrazone (compound 6) 12 prevented induction of miR-182 in activated helper T cells (Fig. 4d) without altering IL-2 production (Supplementary Fig. 5d ). 
A r t i c l e s
To analyze the accessibility of the miR-182 locus, we assessed histone acetylation by chromatin immunoprecipitation with antibodies specific for hyperacetylated histone 4 under T H 1-, T H 2-and T H 17-polarizing conditions. The miR-182 locus was hyperacetylated after 24 h in activated helper T lymphocytes, which indicated a transcriptionally accessible conformation of the locus at this time. Subsequently, the hyperacetylation decreased gradually until it reached the acetylation in naive cells after 6 d (Fig. 4e) .
We wondered whether IL-2 signaling was sufficient to induce miR-182. Naturally occurring regulatory helper T cells do not produce IL-2 after activation but express IL-2R constitutively 13 . In these cells, expression of miR-182 was induced by stimulation with recombinant IL-2, antibody to CD3 (anti-CD3) and anti-CD28 but not by stimulation with recombinant IL-2 alone (Supplementary Fig. 5e) . Thus, the induction of miR-182 expression in helper T cells required both TCR-CD28 signaling and IL-2R signaling.
Promotion of helper T cell clonal expansion by miR-182
We analyzed the role of miR-182 in helper T cell population expansion in loss-of-function and gain-of-function experiments. Treatment of activated helper T lymphocytes in vitro with the inhibitory antagomir-182 decreased the number of viable cells by 50% on day 3 and by 60% on day 4 relative to the number obtained with a control scrambled antagomir (Fig. 5a) . The observed difference in cell numbers was due to more cell death (Fig. 5b) and lower proliferative capacity (Fig. 5c) .
To determine whether treatment with antagomir-182 resulted in less population expansion of helper T cells in vivo, we treated OVAspecific helper T lymphocytes from DO11.10 mice with antagomirs and labeled them with the cytosolic dye CFSE ex vivo. Then we transferred the helper T cells into BALB/c mice and immunized the mice with OVA 1 d after transfer. On day 4 after immunization, we collected lymph nodes and spleens from the mice and analyzed helper T cells. The number of viable helper T lymphocytes was 70% lower after treatment with antagomir-182 (Fig. 5d) . The CFSE labeling indicated much less proliferation after treatment with antagomir-182 (Fig. 5e) .
Inhibition of miR-182 with LNAs led to 30% fewer viable cells (Supplementary Fig. 4d ). We achieved a similar effect by blocking the miR-182-binding site in the Foxo1 3′ UTR with binding site-masking LNAs. This treatment resulted in 20% fewer viable helper T cells (Supplementary Fig. 4d) .
We assessed the effect of constitutive overexpression of miR-182 in vivo with TCR-transgenic helper T lymphocytes from SMARTA mice, which are specific for a lymphocytic choriomeningitis virus (LCMV)-derived peptide 14 . We transduced activated SMARTA Thy-1.1 + T cells with a retroviral vector encoding miR-182, a scrambled control vector or empty vector (Supplementary Fig. 6a) . Fig. 6b ). We then adoptively transferred the transduced SMARTA Thy-1.1 + helper T cells into naive C57BL/6 mice. On day 6 after transfer, we infected mice with LCMV. On day 11 after transfer, we analyzed the population expansion of Thy-1.1 + helper T cells. Helper T cells expressing the miR-182 retroviral vector had 6-fold or 14-fold more population expansion than did those transduced with scrambled control vector or empty vector, respectively (Supplementary Fig. 6c ).
Expression of miR-182 was 40-fold higher in helper T cells transduced with the miR-182 retroviral vector than in those transduced with scrambled control vector (Supplementary
Inhibition of miR-182 decreases OVA-induced arthritis in mice
As inhibition of miR-182 resulted in less clonal expansion of helper T cells in vitro and in vivo, we next analyzed whether inhibition of miR-182 affected the ability of helper T cells to induce inflammation in a mouse model of arthritis. We treated OVA-specific helper T lymphocytes from OT-II mice with antagomir-182 ex vivo and adoptively transferred them into mice deficient in recombinationactivating gene 1. We immunized mice with OVA 1 d after transfer. On day 7 after transfer, we injected OVA into the left knee joint and assessed knee swelling. Knee swelling was about 35% lower in the mice that received antagomir-182-treated helper T cells than in the control mice that received untreated cells (Fig. 6a) . On day 15 after OVA challenge, we determined the absolute number of CD4 + lymphocytes in popliteal and inguinal lymph nodes. Those mice which received antagomir-182-treated cells had 60% fewer viable CD4 + lymphocytes (Fig. 6b) . We used the same experimental set-up to induce arthritis in BALB/c mice given antagomir-182-treated helper T cells from DO11.10 mice. Knee swelling was about 40% less after transfer of antagomir-182-treated helper T cells (Fig. 6c) . Knockdown of miR-182 with antagomirs resulted in significantly lower histological scores for inflammation and tissue destruction (Fig. 6d,e well as bone and cartilage destruction and the formation of pannus tissues, were lower in the mice given antagomir-182-treated cells than in the control group (Fig. 6e) .
DISCUSSION
In helper T lymphocytes, the switch from the resting state in the absence of antigen to proliferative expansion after antigenic activation is tightly controlled by the transcription factor Foxo1 (ref. 15 ).
Resting helper T cells express Foxo1, which induces the IL-7 receptor (IL-7R), Bim and p27 and, in a positive feedback loop, Foxo1 expression itself 21, 22 . IL-7R signaling induces Bcl-2 to neutralize the proapoptotic effects of Bim 5 , whereas p27 Kip1 blocks proliferation 23, 24 . Thus, to enable proliferation after antigenic stimulation, Foxo1 is blocked in activated helper T cells 15 . IL-2 has an important yet not fully understood role in regulating the clonal expansion of activated helper T cells 11 . Immediately after T cell activation, Foxo1 is blocked by TCRdependent post-translational phosphorylation 4 . However, TCR signaling ceases quickly and is 90% lower after 8 h of activation, whereas helper T cells continue to proliferate [25] [26] [27] . In this phase of clonal expansion, the proliferation and survival of the cells are dependent on IL-2 (ref.
3). Understanding of Foxo1 regulation in the IL-2-dependent phase of expansion has been elusive. Here we have shown that IL-2-induced miR-182 regulated Foxo1 at the post-transcriptional level, identifying a further mechanism by which IL-2 can function as a T cell growth factor. Ectopic overexpression of miR-182 in helper T lymphocytes resulted in clonal expansion enhancement of about tenfold, demonstrating the potential of proliferative regulation at the post-transcriptional level.
Ectopic expression, however, might overestimate the relative contribution of miR-182 to the regulation of clonal expansion. Without physiological downregulation of miR-182, inhibition of Foxo1 led to a situation in which all cells of the expanded populations died (data not shown), probably because of a lack of common γ-chain signals provided by IL-2 or IL-7. Blocking physiological expression of miR-182 with antagomirs resulted in clonal expansion that was 60% lower in vitro and 70% lower in vivo. This result is in accordance with data from dicer-deficient helper T cells, which show 75% less clonal expansion 28 . Thus, the IL-2-miR-182 axis constitutes an essential contribution to the clonal expansion of activated helper T cells. Predictably, this contribution depends on the dynamics of IL-2 signaling during expansion. It remains to be determined to what extent this axis contributes to the clonal expansion of memory cells, some of which express little if any IL-2 on their own, such as T H 2 cells and T H 1 cells 29 .
The 60-70% relative contribution of the IL-2-miR-182 axis to the clonal expansion of activated helper T cells reflects the final phase of expansion when neither TCR signaling nor IL-2R signaling is available. In the preceding phase, IL-2R signaling induces miR-182, but it also directly regulates Foxo1 expression by inducing phosphorylation of Foxo1 via phosphatidylinositol-3-OH kinase and the kinase Akt 4 . In the initial phase, TCR-CD28 signaling induces IL-2R and also regulates Foxo1 expression directly via the phosphatidylinositol-3-OH kinase-Akt pathway 4 . During ex vivo activation of naive helper T cells, the TCR-CD28-dependent phase lasts for about 1 d and the directly IL-2-dependent phase lasts from day 1 to day 3, whereas, as we have shown here, the IL-2-miR-182-dependent phase lasts from day 2 to day 4. Both the post-translational regulation by TCR-CD28 and IL-2 and the post-transcriptional regulation by miR-182 result in disruption of the positive feedback loop of Foxo1 expression 21, 22 during clonal expansion. The regulation of miR-182 by IL-2 is critical, as helper T cells, after IL-2-driven clonal expansion, become IL-7 dependent for survival 30 and expression of the IL-7R is Foxo1 dependent 19, 20 . It is notable that prolonged downregulation of Foxo1 by constitutive expression of miR-182 led to the extinction of clonally expanded helper T cells.
Given the critical role of STAT5 signaling for miR-182 induction, it remains unclear why only IL-2R signaling, not IL-7R signaling, induces miR-182. Both cytokines belong to the common cytokine receptor γ-chain family and can activate STAT5 (ref. 11). As we have shown here, STAT5 was the transcription factor that bound to the miR-182 locus. However, our results also suggest that IL-2R signaling on its own cannot induce miR-182. We determined this for regulatory T cells, but it is apparently also true for the other helper T cell subsets, as TCR signaling is always needed to change the accessibility of the miR-182 locus to STAT5. No putative binding sites for the transcription factors NFAT or NF-κB are present in the miR-183-miR-96-miR-182 cluster. Thus, the molecular correlate of this accessibility remains elusive.
The miRNA miR-182 is encoded in a cluster with miR-183 and miR-96 (ref. 7) . Notably, the Foxo1 3′ UTR has overlapping binding sites for miR-96 and miR-182 and a binding site for miR-183 (ref. 33 . Conversely, mimics of miR-182 could be useful to inhibit Foxo1 in expanded helper T cell populations and thus eliminate these cells 34 .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
